Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
Status:
Not yet recruiting
Trial end date:
2028-03-02
Target enrollment:
Participant gender:
Summary
This phase II trial compares the effect of short course radiotherapy (RT) to standard course
RT for the treatment of patients diagnosed with glioblastoma (GBM). The researchers want to
learn whether the shorter course treatment is non-inferior (not worse than the standard of
care), for patients with GBM. Radiation therapy uses high energy x-rays, particles, or
radioactive seeds to kill cancer cells and shrink tumors. Short course radiotherapy delivers
higher doses of radiation over a shorter period of time and may kill more tumor cells and
have fewer side effects.